Navigation Links
FDA Approves Marketing of RMS Subcutaneous Needle Sets
Date:6/1/2011

CHESTER, N.Y., June 1, 2011 /PRNewswire/ -- Repro-Med Systems, Inc., (REPR.PK) announced today that it has received approval from the Food and Drug Administration (FDA) to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo™ RMS Subcutaneous Needle Sets.  The needle sets are intended for the delivery of medication to subcutaneous tissue.  The needle sets have previously been approved and available for use by patients in Canada and Europe.  Repro-Med Systems, Inc. utilizes the name RMS Medical Products.

"The FDA's approval allows patients here in the U.S., where our products are manufactured, to enjoy the benefits realized currently by many patients overseas," said Andrew I. Sealfon, president of the company, based in Chester, NY.  "Although we use a needle which is smaller in gauge than many needles being used for subcutaneous administration of certain drugs, our design results in flow rates comparable to, or better than, the flow rates of the larger needles.  This can result in less pain and discomfort for the patient, less insertion difficulty for the patient and medical personnel, and shorter infusion times," Sealfon added.

The needle sets are an ideal companion for RMS Medical Products' FREEDOM60® Syringe Infusion System, which has enhanced the lifestyle of numerous patients requiring regular drug infusions due to its portability and ease of use.  FREEDOM60® enjoys widespread use by ambulatory patients at home as well as those in healthcare facilities.  "Even though the RMS Subcutaneous Needle Sets provide advanced fluidics, the pricing will be highly competitive, just as FREEDOM60® has been in the infusion pump market," Sealfon said.

The RMS Subcutaneous Needle Sets use custom designed, approximately 26-gauge needles, which have a smaller outside diameter than commonly used 24-gauge needles.  This translates into less "ouch" w
'/>"/>

SOURCE Repro-Med Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Injectable Gel to Treat Fecal Incontinence
2. FDA approves Incivek for hepatitis C
3. FDA Approves Sutent for Rare Type of Pancreatic Cancer
4. FDA Approves New HIV Treatment
5. FDA Approves Victrelis for Hepatitis C
6. FDA Approves New Treatment for Rare Type of Pancreatic Cancer
7. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
8. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
9. FDA Approves New Treatment for Type 2 Diabetes
10. FDA Approves Zytiga for Late-Stage Prostate Cancer
11. FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... new generation of drugs within human and veterinary oncology, ... the Securities and Exchange Commission, in connection with the ... the NASDAQ Stock Market. The number of American Depositary ... price range for the offering have not yet been ...
(Date:7/7/2015)... July 7, 2015  Monopar Therapeutics LLC, an emerging ... that its co-founder and CEO, Chandler D. Robinson ... U.K. Alumni Entrepreneurial Award. The British Council selected one ... India , and the ... made by entrepreneurs who have leveraged their U.K. education ...
(Date:7/7/2015)... DIEGO , July 7, 2015   ... announced today initiation of enrollment and dosing of ... study of ABX-1431, a first-in-class, investigational endocannabinoid system ... platform, which finds new small molecule drug candidates ... enzymes with important regulatory roles in human physiology ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 2Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 3
... SUNNYVALE, Calif., Oct. 19, 2011 ... premier radiation oncology company, announced today that it ranked 274th ... growing technology, media, telecommunications, life sciences and clean technology companies ... based on percentage fiscal year revenue growth from 2006 to ...
... therapy games can help people with Parkinson,s disease improve their ... by the UCSF School of Nursing and Red Hill Studios, ... the subjects in the three-month research project showed small improvements ... and Red Hill were the first research team in the ...
Cached Medicine Technology:Accuray Ranked 274th Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 2Accuray Ranked 274th Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 3Accuray Ranked 274th Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 4Red Hill Studios and UCSF Announce Computer Games Help People with Parkinson's Disease 2Red Hill Studios and UCSF Announce Computer Games Help People with Parkinson's Disease 3
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for Disease Control ... , and the Multicultural AIDS Coalition $3.78 million for a five-year HIV ... with men (MSM) and transgender women, the groups at highest risk of HIV ...
(Date:7/7/2015)... MD (PRWEB) , ... July 07, 2015 , ... SC&H ... of Service, which aims to give back to the community through company-wide volunteering efforts. ... from SC&H Group dedicate the day to assisting those in need throughout Baltimore and ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... to further enhance the experience for its patient community using its IDF ePHR, ... allows patients with primary immunodeficiency diseases (PI) to easily track their health information, ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the ... HSA holders. HSAstore.com makes it simple to use, spend and manage HSA funds with ... their accounts. , According to a report by Devenir , approximately 13.8 ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... America ... others. California Casualty’s Nominate A Hero program offers a special way to ... a well-deserving hero receives a $250 gift card and their place on the “Wall ...
Breaking Medicine News(10 mins):Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2
... Joint Commission,International (JCI) today announced its accreditation by ... is a division of Joint Commission,Resources, Inc. (JCR), ... JCI is a global leader in health care ... hospitals in 27 countries. This external,endorsement by ISQua ...
... Jan. 2 Gen-Probe Incorporated,(Nasdaq: GPRO ) announced ... JPMorgan Healthcare Conference on Wednesday, January 9, 2008 at,approximately ... is scheduled to be webcast live and may be ... Gen-Probe,s website at, http://www.gen-probe.com . The webcast will be ...
... opioids more often than blacks, Hispanics , , WEDNESDAY, Jan. 2 ... in significant pain, you are less likely to be prescribed ... white, new research shows. , The reasons for the disparity ... effective pain treatment in the ER as often as whites ...
... Study undercuts notion that they,re given to help the poor, ... Most free drug samples go to wealthy and insured patients, ... most, Harvard researchers report. , In fact, more than four-fifths ... one-fifth are uninsured and less than one-third have low incomes ...
... Il-22 gene delivers the goods and decreases intestinal ... inflammatory bowel disease (IBD), Crohn disease (CD) and ulcerative ... factor IL-22 can have both IBD promoting and IBD ... Massachusetts General Hospital, Boston, have established that IL-22 ameliorates ...
... a non-invasive way to determine the existence and extent ... of pharmacologic strategies to combat the condition. These findings ... published by John Wiley & Sons on behalf of ... (AASLD). The article is also available online at Wiley ...
Cached Medicine News:Health News:Joint Commission International Achieves Accreditation from ISQua 2Health News:Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference 2Health News:Minorities Less Likely to Get Powerful Painkillers in ER 2Health News:Minorities Less Likely to Get Powerful Painkillers in ER 3Health News:Most Free Drug Samples Go to Wealthy and Insured 2Health News:Most Free Drug Samples Go to Wealthy and Insured 3Health News:JCI online early table of contents: Jan. 2, 2008 2Health News:JCI online early table of contents: Jan. 2, 2008 3Health News:JCI online early table of contents: Jan. 2, 2008 4Health News:JCI online early table of contents: Jan. 2, 2008 5Health News:JCI online early table of contents: Jan. 2, 2008 6Health News:JCI online early table of contents: Jan. 2, 2008 7Health News:JCI online early table of contents: Jan. 2, 2008 8Health News:JCI online early table of contents: Jan. 2, 2008 9Health News:MRI techniques evolving towards better assessment of liver fibrosis 2
Facial Mask...
Deluxe Abdominal Binders...
CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from ...
Ideal for abdominal and flank procedures....
Medicine Products: